Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and MutationKyaw Zwar Myint(Mahidol University), Rutaiwan Tohtong(Mahidol University)PharmaceuticalsFebruary 2, 202410.3390/ph17020197Cited by 7SaveCiteExport RISWatch citationsRelated PapersGadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway|Oncology Letters|2017|8PD98059-inhibited invasion of Dunning rat prostate cancer cells involves suppression of motility but not MMP-2 or uPA secretion|Oncology Reports|2006|5